TY  - JOUR

T1  - Proliferation and AKT activity biomarker analyses after capivasertib (AZD5363) treatment of patients with ER+ invasive breast cancer (STAKT)

JO  - Clinical Cancer Research

UR  - http://eprints.whiterose.ac.uk/159608/

PY  - 2020/04/01

AU  - Robertson JFR

AU  - Coleman RE

AU  - Cheung K-L

AU  - Evans A

AU  - Holcombe C

AU  - Skene A

AU  - Rea D

AU  - Ahmed S

AU  - Jahan A

AU  - Horgan K

AU  - Rauchhaus P et al

ED  - 

DO  - DOI: 10.1158/1078-0432.ccr-19-3053

PB  - American Association for Cancer Research (AACR)

VL  - 26

IS  - 7

SP  - 1574

EP  - 1585

Y2  - 2025/10/10

ER  -